Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Ron Tilles

- PMLiVE

FDA clears generic of Daraprim, the ‘poster drug’ for price-gouging

Drug hit headlines after price jumped from $13.50 to $750 overnight

- PMLiVE

Post-Shkreli KaloBios pledges transparent pricing

Will seek input from “key stakeholders” and share reasoning behind pricing of drugs

- PMLiVE

KaloBios files for bankruptcy protection

San Francisco biopharma's shares imploded in the wake of Martin Shkreli's arrest

- PMLiVE

Shkreli fallout claims Turing jobs and KaloBios’ listing

Both firms continue to suffer with job cuts and de-listing from the Nasdaq

- PMLiVE

Update: Shkreli resigns as Turing CEO, ousted from KaloBios

Shares in KaloBios had been hit hard when news of his arrest broke

- PMLiVE

Turing CEO Shkreli arrested by FBI in securities fraud probe

Accused of illegally using stock from biopharma firm Retrophin to pay off debts

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links